These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2788840)

  • 1. Biochemical evidence for the GABA regulation of vasopressin levels in microdissected brain structures after servo-controlled hypotension.
    Magnusson A; Höglund U; Sjöquist M
    Neurosci Lett; 1989 Jul; 101(3):281-7. PubMed ID: 2788840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for the involvement of a GABA-mediated inhibition in the hypovolaemia-induced vasopressin release.
    Knepel W; Nutto D; Hertting G
    Pflugers Arch; 1980 Nov; 388(2):177-83. PubMed ID: 7192856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasopressin secretion as a possible target of the gamma-aminobutyric acid-mediated component of the corticosteroid feedback effect.
    Acs Z; Lutz-Bucher B; Koch B; Stark E
    J Endocrinol; 1985 Dec; 107(3):303-7. PubMed ID: 4067485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular effects of 3-mercaptopropionic acid and levels of GABA in regions of the brain of guinea-pigs.
    Alsip NL; Simon JR; Fohl LD; DiMicco JA
    Neuropharmacology; 1984 Mar; 23(3):349-57. PubMed ID: 6728126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response of the cockroach brain gamma-aminobutyric acid system to isonicotinic acid hydrazide and mercaptopropionic acid.
    Pandey A; Singh R
    Biochem Int; 1985 Feb; 10(2):213-20. PubMed ID: 3994733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central inhibition by gamma-aminobutyric acid and muscimol of the release of vasopressin and oxytocin by an osmotic stimulus in the rat.
    Bisset GW; Chowdrey HS; Fairhall KM; Gunn LK
    Br J Pharmacol; 1990 Mar; 99(3):529-35. PubMed ID: 2331582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gabaergic stimulation inhibits central actions of angiotensin II: pressor responses, drinking and release of vasopressin.
    Unger T; Bles F; Ganten D; Lang RE; Rettig R; Schwab NA
    Eur J Pharmacol; 1983 May; 90(1):1-9. PubMed ID: 6873170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous determination of gamma-aminobutyric acid and glutamic acid in the brain of 3-mercaptopropionic acid-treated rats using liquid chromatography-atmospheric pressure chemical ionization mass spectrometry.
    Ma D; Zhang J; Sugahara K; Ageta T; Nakayama K; Kodama H
    J Chromatogr B Biomed Sci Appl; 1999 Apr; 726(1-2):285-90. PubMed ID: 10348197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of GABA in environmental temperature-induced change in body temperature.
    Biswas S; Poddar MK
    Methods Find Exp Clin Pharmacol; 1988 Dec; 10(12):747-9. PubMed ID: 3236943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurosteroid regulation of oxytocin and vasopressin release from the rat supraoptic nucleus.
    Widmer H; Ludwig M; Bancel F; Leng G; Dayanithi G
    J Physiol; 2003 Apr; 548(Pt 1):233-44. PubMed ID: 12588901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Potentiation of acupuncture analgesia by GABA in the dorsal raphe nucleus].
    Ye WL; Feng XC
    Sheng Li Xue Bao; 1986 Apr; 38(2):123-31. PubMed ID: 3490696
    [No Abstract]   [Full Text] [Related]  

  • 12. GABA-A agonist muscimol inhibits stimulated vasopressin release in the posterior pituitary of Sprague-Dawley, Wistar, Wistar-Kyoto and spontaneously hypertensive rats.
    Magnusson AM; Meyerson BJ
    Neuroendocrinology; 1993 Nov; 58(5):519-24. PubMed ID: 8115020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic anticonvulsant effects of a GABA agonist and glycine.
    Seiler N; Sarhan S
    Gen Pharmacol; 1984; 15(4):367-9. PubMed ID: 6489732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GABAergic mechanisms in nucleus tractus solitarius alter blood pressure and vasopressin release.
    Catelli JM; Giakas WJ; Sved AF
    Brain Res; 1987 Feb; 403(2):279-89. PubMed ID: 3828822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GABAergic projection from the arcuate nucleus to the supraoptic nucleus in the rat.
    Ludwig M; Leng G
    Neurosci Lett; 2000 Mar; 281(2-3):195-7. PubMed ID: 10704776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postmortem increase of GABA levels in peripheral rat tissues: prevention by 3-mercapto-propionic acid.
    Erdö SL
    J Neural Transm; 1984; 60(3-4):303-14. PubMed ID: 6527141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postnatal development of transmitter systems: sexual differentiation of the GABAergic system and effects of muscimol.
    Flügge G; Wuttke W; Fuchs E
    Int J Dev Neurosci; 1986; 4(4):319-26. PubMed ID: 3455593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the glutamic acid decarboxylase inhibitor 3-mercaptopropionic acid on the synthesis of brain GABA in vivo and postmortally.
    Lindgren S
    J Neural Transm; 1983; 58(1-2):75-82. PubMed ID: 6655469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of GABAergic drugs in vivo on high-affinity choline uptake in vitro in mouse hippocampal synaptosomes.
    Miller JA; Richter JA
    J Neurochem; 1986 Dec; 47(6):1916-8. PubMed ID: 3772382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Release of [3H]- and endogenous GABA from slices of the rat medulla oblongata: modification by 3-mercaptopropionic acid, nipecotic acid and diaminobutyric acid.
    Kihara M; Amano H; Misu Y; Kubo T
    Arch Int Pharmacodyn Ther; 1989; 298():50-60. PubMed ID: 2757467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.